Posts in category Healthcare


Canaccord Lifts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Cuts Endo International plc

Canaccord analysts are out with neutral standpoints on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Endo …

Read more

BTIG Gets Bullish on Kite Pharma Inc (KITE) and Axi-Cel’s Pathway to Approval in DLBCL

BTIG analyst Dane Leone sees new reason to step away from the sidelines on Kite …

Read more

Acorda Therapeutics Inc (ACOR): Key Takeaways from CVT-301 Presentation at MDS

Yesterday afternoon, Acorda Therapeutics Inc (NASDAQ:ACOR) presented data from its Phase 3 SPAN-PD clinical trial of …

Read more

bluebird bio Inc (BLUE) Leads the Way in the Next Wave of CAR-Ts

Cowen analyst Eric Schmidt is out today with a research note on shares of bluebird bio Inc …

Read more

Rodman & Renshaw Encouraged on Rexahn Pharmaceuticals, Inc. (RNN) Following ASCO Update

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) offered a key glimpse into its advanced muscle invasive bladder cancer …

Read more

Acorda Therapeutics Inc (ACOR) Is Undervalued for CVT-301’s Potential: Cowen

Acorda Therapeutics Inc (NASDAQ:ACOR) shares climbed nearly 10% to $16.80 in after-hours trading Monday, after …

Read more

ASCO: Puma Biotechnology Inc (PBYI) Receives Bullish Review from J.P. Morgan

J.P. Morgan’s Cory Kasimov is attending the annual American Society of Clinical Oncology, or ASCO, …

Read more

BTIG Shares Two Cents on Juno Therapeutics Inc (JUNO) Following ASCO Abstract

In a research report published Monday, BTIG analyst Dane Leone reiterated a Neutral rating on …

Read more

Endocyte, Inc. (ECYT): Cowen’s Downgrade Adds Fuel to the Fire

In a research report released Friday, Cowen analyst Boris Peaker downgraded shares of Endocyte, Inc. (NASDAQ:ECYT) from …

Read more

Synergy Pharmaceuticals Inc (SGYP): Weekly Rx’s Hit a New High

BTIG analyst Tim Chiang weighs in on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), following recent data that showed strong growth …

Read more